SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001395064-20-000153
Filing Date
2020-10-09
Accepted
2020-10-09 06:11:31
Documents
4
Period of Report
2020-10-09

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k-100920.htm 6-K 48202
2 GRAPHIC image01.jpg GRAPHIC 39905
3 GRAPHIC image02.jpg GRAPHIC 133296
4 GRAPHIC image11.jpg GRAPHIC 91013
  Complete submission text file 0001395064-20-000153.txt   395915
Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Filer) CIK: 0001395064 (see all company filings)

IRS No.: 000000000
Type: 6-K | Act: 34 | File No.: 001-38757 | Film No.: 201232033
SIC: 2834 Pharmaceutical Preparations